FutuurKullanılabilirliği kontrol etDoğrulanmış sonuçlanma verisiGüncel ima edilen olasılık
3-5 52.5%4 seçenek arasında lider
3-5 52.5%Piyasa kalitesi
32 / 100
Düşük kalite24s Hacim
—
Likidite
₺54,2 B
Düşük likiditeİşlemciler
17
Yorumlar
0
Piyasa verileri
3 dakika önce güncellendi
Trendler
Kurallar
This event predicts the total number of distinct interventional human clinical trials that have started in Prospera as of 11:59 PM CST on December 31, 2026.
- The Primary Designated Source (PDS) will be the Prospera Business Registration Report, used together with public clinical-trial registry records (ClinicalTrials.gov or a WHO primary registry) to identify qualifying trials.
- If the total number of distinct interventional human clinical trials meeting all criteria (interventional in humans; Study Start Date on or before Dec 31, 2026; and a registry record that either (i) explicitly lists a study location in Próspera/Prospera/Prospera ZEDE, or (ii) lists Roatán, Honduras and is corroborated by an authoritative source stating the site is in Prospera) falls within the value range defined for tone of the listed markets, that market will resolve to "Yes".
- All other markets will resolve to "No".
- Observational studies do not count, and each distinct registry identifier counts once.
- If registry location is unclear, corroboration may use sponsor pages/press releases, Prospera official gazette/registry pages, or reputable news/trade publications.
